Ticker LaunchLondon · AIM · IPO · BELL
Belluscura Plc
Belluscura Plc (BELL) was admitted to AIM on May 28, 2021, raising £17.5M at 45p per share. Its market capitalization at admission was about £51M. SPARK Advisory Partners acted as nominated adviser, with Dowgate Capital (Sole Broker and Bookrunner) as broker.
Belluscura is a medical device developer focused on lightweight portable oxygen enrichment technology. Its first product is the X-PLO2R, an FDA-cleared portable oxygen concentrator. It was established in the UK in December 2015.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- BELL
- Admitted
- May 28, 2021
- Offer price
- 45p
- Raised
- £17.5M
- Market cap at admission
- £51M
- Nominated adviser
- SPARK Advisory Partners
- Brokers
- Dowgate Capital (Sole Broker and Bookrunner)
- Sector
- Biotech & pharma
- Country
- United Kingdom / United States (Plano, Texas)
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Arecor Therapeutics PlcAIM · Jun 3, 2021
- Aquila Energy Efficiency Trust PlcMain Market · Jun 2, 2021
- Trellus Health PlcAIM · May 28, 2021
- Taylor Maritime Investments LimitedMain Market · May 27, 2021
- Dianomi PlcAIM · May 24, 2021
- Kitwave Group PlcAIM · May 24, 2021